Venture capital fund
Every published round Lightstone Venture took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
Companies Lightstone Venture has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| No portfolio companies recorded yet. | ||||
Fund closes reported for Lightstone Venture, as distinct from the investments it has made.
Companies Lightstone Venture has backed that another company then bought. An exit for the holding, not a deal Lightstone Venture did.
Stories naming Lightstone Venture. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
US-Singapore biotech Allay Therapeutics has closed a $60 million Series C round led by Arboretum Ventures, with several healthcare investors taking part, to advance its long-acting post-surgical pain candidate into late-stage trials.